Figure 2From: Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial Histograms denoting simulated steady-state T>MIC for subjects receiving infusions of meropenem. Each chart presents different group of subjects depending on GA and PNA. The T>MIC was calculated based on the EUCAST breakpoints for Enterobacteraciae which is 2 mg/L. PNA - postnatal age, GA - gestational age; ss - steady stateBack to article page